| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |